Close

Priorclave Appoints New CEO for its American Operation

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Leading British autoclave specialist Priorclave is delighted to announce their appointment of Barbra Wells as President and CEO to head up its American operation.    

She joined the North American organisation three years ago, predominantly in a marketing role and has been instrumental in driving the growth of the company in the States.

For this leading British autoclave design and manufacturing specialist Priorclave, America is rapidly becoming one of its major overseas success stories. For cultural, regulatory, and practical reasons, North America had proven a challenging market, however during more recent years Priorclave North America has been instrumental in overcoming these obstacles and educating customers as to the notable savings they can gain-in reduced energy, water, and maintenance costs-by adopting a proper research-grade laboratory autoclave.

Priorclave’s cylindrical laboratory and research autoclave ranges, built to ASME standard in the UK factory, are in particular achieving considerable attention in the States due to their over efficiencies.

Commenting Barbra says, ““The US continues to be a strong market for the Priorclave brand of autoclaves because our ‘on-demand’ steam sterilizers are designed for research laboratories, not 24-hour medical operation. Much of our success revolves around the reliability, sustainability, and flexibility of these leading British designed autoclaves. These are overriding benefits that drive our success because laboratory budgets are an issue here in America, particularly in the education sector where every dollar is counted.“

Barbra is delighted and eager to take the helm of a company that’s leading the way in lab efficiency in North America.

Latest stories

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back